期刊文献+

高效液相色谱法测定血液中盐酸安非拉酮浓度 被引量:4

DETERMINATION OF AMFEPRAMONE HYDROCHLORIDE IN PLASMA BY HPLC
暂未订购
导出
摘要 目的:采用HPLC法测定盐酸安非拉酮血药浓度,旨在为盐酸安非拉酮在体内的血药浓度分析和法医学中毒检测提供方法。方法:色谱柱采用YWG- C18Φ4.6×150m m 10μ,流动相为甲醇- 0.01m ol/L,醋酸铵(35:65,用氨水调pH7.5),茶碱为内标,检测波长为254nm ,血浆样品应用SPE固相小柱萃取。结果:安非拉酮线性范围为(5~500)μg/L(r= 0.9994),最低检测浓度5μg/L,平均方法回收率为97.03% 。日内、日间RSD均小于5% 。结论:此方法稳定、可靠。 Objective: A HPLC method has been developed to determine the concentration of amfepramone hydrochloride in plasma. The study devoted to analysis of amfepramone hydrochloride in plasma and toxication in forensic practice. Methods: They were separated and determined on SPE column and Φ4.6×150mm 10μYWG C 18 column respectively, using methanol 0.1mol/L ammonium acetate (35∶65) as the mobile phase, theophylline(theocin) as internal standard, UV 254nm detector. Results: The ranges of catibration curves were 5~500μg/L( r =0.9994) and lowest detectable concentration of amfepramone hydrochloride was 5μg/L, while the average recovery of the methods was 97.03%. The RSD for inter day and intraday assays were all less than 5%. Conclusion: The method is stable and reliable. The way was suitable for the analysis of amfepramone hydrochloride in plasma and determination of this toxication in forensic practice.
出处 《天津医科大学学报》 1999年第3期17-18,共2页 Journal of Tianjin Medical University
关键词 盐酸安非拉酮 高效液相色谱法 血药浓度 amfepramone hydrochloride HPLC drugs concentration in plasma
  • 相关文献

参考文献3

  • 1席先成,周冰心,张怡泰,赵锦玲.安非拉酮应用于单纯性肥胖症84例[J].中国新药与临床杂志,1991,16(6):362-363. 被引量:4
  • 2杨存社.盐酸安非拉酮片中毒一例[J].陕西医学杂志,1995,24(5):320-320.
  • 3王贤才(译).肥胖用药.临床药物大典[M].青岛:青岛出版社,1994.1765-1766.

共引文献3

同被引文献50

  • 1汪国权,王宏.减肥茶中芬氟拉明含量测定方法[J].上海预防医学,1998,10(9):390-392. 被引量:2
  • 2崔建芳,李农,崔凯荣,周屹,周同惠.苯丙胺类药物的气相色谱及气质联用检测[J].药物分析杂志,1994,14(4):3-7. 被引量:4
  • 3徐朝霞,唐树荣.高效液相色谱法测定马吲哚片含量[J].色谱,1995,13(1):72-73. 被引量:4
  • 4王玉,王丽,宋瑞雪.酸性染料比色法测定盐酸芬氟拉明片的含量[J].药物分析杂志,1995,15(4):40-41. 被引量:3
  • 5Valentine JL,Kcams GL, Sparks C, ct al. GC-MS determination of amphetamine and methamphetamine in human urine for 12 hours following oral administration of dextromethamphetaminc:lack of evidence supporting the established forensic guidelines for methamphetamine confirmation. J Anal Toxicol, 1995, 19(7): 581-590.
  • 6Elsohly MA, Stanford DF, Sherman D, ct al. A procedure for eliminating intcxfcrenccs from ephedrine and related compounds in the G-C/MS analysis of amphetamine and methamphetamine.J Anal Toxicol 1992) 16(2): 109-111.
  • 7Brooks KE,Smith NS.Lack of fommtion of methamphetamine-like artifacts by the monoacetatcs of pseudoephedrine and related compounds in the GC/MS analysis of urineexlracts. J Anal Toxicol, 1993, 17(7): 441-442.
  • 8Lillsunde P,Michelson L,Forsstrom T,et al.Comprehonsive drug screening in blood for detecting abused drugs or drugs potentially hazardous for traffic safety. Forensic Sci Int,1996, 77(3): 191-210.
  • 9Taylor RW, Le SD, Philip S,et al.Simultaneous identification of amphetamine and mcthamphctaminc using solid-phase extraction and gas chromatograph/nitrogen phosphorous dotection or gas chromatography/mass spectrometry. J Anal Toxicol, 1989: 13(5): 293-295.
  • 10Jonsson J, Kronstrand R, Hatanpaa M. A convenient derivatization method for the determination of amphetamine and related drugs in urine. J Forensic Sci, 1996,41 (1): 148 - 151.

引证文献4

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部